Year None202320222021202020192016201520142006 Jul 27, 2023 CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference Jul 25, 2023 CVRx Reports Second Quarter 2023 Financial and Operating Results Jul 11, 2023 CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023 Jun 22, 2023 CVRx Set to Join Russell 2000 & 3000 Indexes May 25, 2023 CVRx to Present at the William Blair 43rd Annual Growth Stock Conference Apr 27, 2023 CVRx Reports First Quarter 2023 Financial and Operating Results Apr 20, 2023 CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023 Mar 21, 2023 Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure Mar 16, 2023 CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call Feb 21, 2023 CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial Pagination Current page 1 Page 2 Next page next Last page last Displaying 1 - 10 of 13
